Case Summary:     

We are pleased to share the success story of an EB-2 NIW (National Interest Waiver) approval granted to a research assistant from Iran whose research is helping advance nanobiotechnology solutions for occupational safety. At the time of filing, the client was pursuing doctoral studies in the United States and had already produced impactful work on enzymatic decontamination methods to reduce carcinogen exposure in firefighter protective gear.

Enzymatic Nanotechnology for Public Safety

The client’s proposed endeavor focuses on developing and applying immobilized enzymes on nanomatrices to break down toxic polycyclic aromatic hydrocarbons (PAHs) that accumulate on firefighter personal protective equipment. This innovative research directly supports public health and occupational safety by mitigating cancer risks among first responders. By combining principles from nanotechnology and enzymology, the client’s work enables efficient detoxification of hazardous residues and improves the performance and longevity of protective gear, addressing national concerns in emergency preparedness and first responder health.

Scholarly Output and Field Influence

To support the petition, NAILG presented evidence of the client’s growing academic contributions and recognition within the scientific community. At the time of filing, the client had authored 6 peer-reviewed journal articles, including 1 as the first author. These publications focus on advancing nanobiotechnology applications for decontamination and public health protection. According to Google Scholar, the client’s work had been cited 35 times by researchers developing related methods in environmental remediation and occupational health. These citations demonstrate the practical relevance and emerging influence of the client’s research in addressing critical national priorities.

Independent Expert Endorsements

The NIW petition included recommendation letters from independent experts in nanotechnology and pharmaceutical sciences.

One expert stated:

“[Client’s] work on the synthesis and application of silver nanoparticles for antimicrobial functions has dramatically advanced virology and antiviral research as well as the state of therapeutics for addressing the global impact of HIV and HSV infections, which affect millions of people worldwide each year.”

Others highlighted the innovative nature of the client’s enzymatic research and its potential to revolutionize how occupational contaminants are managed in high-risk settings.

Strategic Petition and Approval Outcome

NAILG presented a compelling case outlining the client’s qualifications, research alignment with national priorities, and capability to continue this work independently. With FEMA-backed research, strong academic metrics, and well-documented real-world impact, the client’s petition was approved without an RFE.

We are proud to have supported this outstanding researcher in securing NIW approval and look forward to their continued contributions to U.S. innovation and public health. This approval further demonstrates NAILG’s commitment to supporting researchers whose work advances national safety and scientific leadership.